Ignite Creation Date:
2025-12-25 @ 4:03 AM
Ignite Modification Date:
2026-02-28 @ 7:10 AM
Study NCT ID:
NCT04617002
Status:
APPROVED_FOR_MARKETING
Last Update Posted:
2025-08-20
First Post:
2020-10-29
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Intermediate-size Expanded Access to ONC201 for Patients With H3 K27M-mutant and/or Midline Gliomas
Sponsor:
Jazz Pharmaceuticals
Organization: